Deep Intelligence Across Industries

Company Headquarter: ‎ California, US Founded: 1989 Workforce: ~200 Company Working: Sorrento Therapeutics (Sorrento) is an antibody-centric, clinical stage biopharmaceutical company that develops new treatments for cancer, inflammation, and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar antibodies, as well as clinical CAR-T therapies targeting solid tumors. It has a unique immuno-oncology (I-O) portfolio, comprised of a wide array of innovative and synergistic assets, such as a broad fully human antibody library (G-MAB), clinical stage CAR-T, intracellular targeting antibodies (iTAbs), antibody-drug conjugates (ADC), and an oncolytic virus (Sephrehvir).

Company Headquarters: UK, Europe Founded: 2014 Company Working: Autolus Therapeutics PLC (Autolus), a biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 for the treatment of multiple myeloma; AUTO4 and AUTO 5 for T cell lymphoma; and AUTO6 and AUTO7 to treat solid tumors. The company functions as a single operating segment, which is the business of developing and commercializing gene therapies.

Company Headquarters: California, US Founded: 2009 Company Working: Kite Pharma, a clinical-stage biopharmaceutical company that is focused on the development and commercialization of novel cancer immunotherapy products. The company has been developing a pipeline of engineered, autologous cell therapy-based product candidates for the treatment of solid and hematological malignancies. Its lead product candidate is KTE-C19, a CAR-based therapy is in Phase II of clinical trials. KTE-C19 is likely to aid in the treatment of patients with relapsed or refractory aggressive diffuse large B cell lymphoma, primary mediastinal B cell lymphoma, and transformed follicular lymphoma. The company has one operating segment, which primarily focuses on the discovery, development, and commercialization of innovative medicines in areas of unmet medical need. The company operates as a cell therapy subsidiary of Gilead Sciences, Inc.

Company Headquarter: Milan, Italy Founded: 1994 Workforce: 3,450+ Company Working: Bracco Diagnostic Inc. (Bracco) is an international healthcare company, majorly focused on diagnostic imaging products. It has a wide portfolio consisting of over 1,800 patents. Its main products include contrast agents and medical substances used to improve the diagnostic accuracy of biomedical imaging. Its products are sold in over 100 countries, both directly and indirectly through branches, joint ventures, license, and distribution agreements. The company holds a leading position in important geographical areas such as Japan, North America, and Europe. Bracco’s production activities are carried out in Italy, Canada, Switzerland, Germany, Japan, and China.

Company Headquarters: Texas, US Founded: 2016 Company Working: Nuvectra Corporation offers its devices for neurological indications such as spinal cord stimulation. Moreover, the company is continuously engaged in improving and developing medical devices for neurological conditions, such as sacral nerve stimulation and deep brain stimulation.

Company Headquarters: California, US Founded: 2008 Company Working: The company designs, develops, and manufactures implantable devices for the treatment of neurological disorders. The company is continuously engaged in research and development of neurostimulation devices. The company is recognized for its innovation. It offers RNS System in the treatment of seizure.

Company Headquarters: Egypt Founded: 2012 Company Working: Clarus Company is an innovative dental company that specializes in cosmetic dental products. The company provides the latest technology in clear aligner treatments and manufacturing. Its products reduce the treatment time by 30% at a very economical price. Its standard clear aligners are made of traditional clear aligner sheets and are worn for seven days. Smart clear aligners are made of specially engineered clear aligner sheets. These are worn for 15 days. Smart clear aligners are 30% faster and require less time than any other aligner systems worldwide.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Franklin Gothic Medium",sans-serif;} Oracle Corporation was established in 1977, with its headquarters in California, U.S. The company manufactures application software, hardware systems and provides solutions for other services. The company offers services in three major areas such as software as a service, platform as a service and infrastructure as a service. Under homomorphic encryption, the company provides IT infrastructure solutions such as data encryption. Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Franklin Gothic Medium",sans-serif;} The company has production centres, research and development engineers, personalization & data centres across the globe in regions such as U.S., India, Japan, U.K., Germany, New Zealand, Canada and Russia. The main strategy of the company is to invest more in research & development to innovate new products which can be offered through cloud and on premise software. It reported revenue of USD 37,047 million in FY2016.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0in; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin;} Company Headquarters Walldorf, Germany Founded: 1972 Workforce: ~96,498 Company Working: SAP SE (SAP) is a leading provider of enterprise applications and software solutions. The company offers software-related services and enterprise application software globally. SAP SE operates through the applications, technology & services, and SAP business network business segments. The applications, technology & services segment generates its revenue primarily by selling software licenses and subscriptions to cloud applications and related services, as well as by implementing software products and education services. The SAP business network segment has basically emerged from combining all SAP network offerings into one network, which entirely covers temporary workforce sourcing, other procurement, end-to-end travel, and business travel expense management. Apart from Germany, the company operates through offices located in the Americas, Asia-Pacific, the Middle East & Africa and, Europe. SAP SE has several subsidiaries, including Hybris, Success Factors, Fieldglass, and SAP Ariba, situated at various locations globally. The company has approximately 15,000 partners globally.

### Positioning statement (150 words) Starbucks is the world's largest specialty coffee company and, by a wide margin, the dominant global operator of branded coffeehouses. It vertically integrates green-coffee sourcing, proprietary roasting and a 41,000-store retail estate spanning 89 markets, monetised through three channels: directly operated coffeehouses, a licensed store network run by regional partners, and a consumer-packaged-goods and foodservice franchise operated principally through the Global Coffee Alliance with Nestlé. The economic engine is North America, which generated 74% of fiscal 2025 revenue. Following two years of comparable-sales erosion, the company is executing a comprehensive operational reset — "Back to Starbucks" — under chairman and chief executive Brian Niccol, appointed September 2024. That reset has produced four consecutive quarters of comparable-sales growth through Q3 fiscal 2026 and two consecutive quarters of margin expansion, alongside a decisive shift in capital structure: the April 2026 divestiture of a controlling interest in Starbucks China converts the company's second-largest market to an asset-light licensing relationship. --- ### 2.1 The company's own characterisation In its fiscal 2025 Annual Report on Form 10-K, Starbucks describes itself as the premier roaster, marketer and retailer of specialty coffee worldwide, operating in 89 markets. It purchases and roasts high-quality coffees, which it sells alongside handcrafted coffee, tea and other beverages together with food through company-operated stores (which the company calls "coffeehouses"). It also sells coffee and tea products and licenses its trademarks through other channels — licensed stores, and grocery and foodservice via the Global Coffee Alliance with Nestlé S.A. Beyond the flagship Starbucks Coffee brand, the company markets goods and services under the Teavana, Ethos and Starbucks Reserve marks. The company states that its primary objective is to sustain Starbucks' standing as one of the most recognised and respected brands globally, and that continuous investment in brand and operations will deliver long-term revenue and income growth. That includes expanding the global store base in both mature markets such as the United States and higher-growth markets, and optimising the mix of company-operated and licensed stores. It emphasises beverage, equipment, process and technology innovation, including its digital platform. ### 2.2 Independent characterisation Starbucks is best understood as three economically distinct businesses sharing one brand and one supply chain: **(a) A capital-intensive, high-fixed-cost retail operator.** Company-operated stores generated 82.7% of fiscal 2025 net revenue ($30,744.8m of $37,184.4m). This business carries the full weight of store labour, occupancy and depreciation. In fiscal 2025 store operating expenses reached 55.5% of company-operated store revenue, up from 51.4% in fiscal 2024 — a 410-basis-point deterioration that is the single most important line item in understanding the fiscal 2025 profit collapse. Almost all of the 21,514 company-operated stores at fiscal 2025 year-end were leased, which is why operating lease liabilities of $10.5bn sit alongside $16.1bn of financial debt on the balance sheet. **(b) A royalty-and-wholesale licensing business.** Licensed stores produced 11.7% of fiscal 2025 revenue ($4,350.4m). Under this model Starbucks earns a margin on branded product and equipment sold to the licensee plus a royalty on the licensee's retail sales; the licensee bears operating costs and capital expenditure. Licensed stores carry lower gross margin but structurally higher operating margin than company-operated stores. This is the model Starbucks is now deliberately migrating toward: the April 2026 conversion of roughly 7,991 China company-operated stores to licensed status was the largest single such shift in the company's history. **(c) A consumer-packaged-goods and foodservice franchise.** "Other" revenue — 5.6% of fiscal 2025 revenue ($2,089.2m) — is recorded largely in Channel Development and comprises packaged coffee, tea and ready-to-drink sales outside the store estate plus Nestlé royalties. This is by far the highest-margin part of the enterprise: Channel Development operating margin was 47.3% in fiscal 2025 and 52.1% in Q3 fiscal 2026. It is also the least capital-intensive, since Nestlé controls distribution and, in some cases, roasting and packaging of Starbucks packaged products outside Starbucks stores. ### 2.3 Revenue model composition *(FY2024 and FY2025 from the Q4 FY2025 earnings release, 29 October 2025; FY2023 components derived from the FY2023 Form 10-K and shown as approximate.)* *(FY2025 Form 10-K, segment note.)* Within company-operated stores specifically, the retail sales mix in fiscal 2025 was 73% beverages, 23% food and 4% other, versus 74%/23%/3% in fiscal 2024 and 74%/22%/4% in fiscal 2023 (FY2025 Form 10-K). The food attach rate has been a deliberate management lever; Q3 fiscal 2026 ticket growth of 3.5% in North America was attributed in part to food attach and beverage modification. ### 2.4 Value chain position Starbucks occupies an unusually long stretch of the coffee value chain for a retailer. It controls substantially all green-coffee purchasing, roasting, packaging and global distribution for its own operations, operates ten farmer support centres (including one in Yunnan Province, China) staffed with agronomists, and owns most of its roasting plants while leasing the majority of warehousing and distribution facilities. Upstream, it does not own coffee farms at scale; it purchases from producers, trading companies and exporters using fixed-price and price-to-be-fixed commitments, hedged with forwards, futures and collars. Downstream in the CPG channel it has ceded distribution to Nestlé in exchange for an upfront payment and an ongoing royalty stream — an asset-light structure that materially improves returns but reduces control. ### 2.5 Customer types and end-markets - **Retail consumers** — the overwhelming majority of revenue, transacting in-store, via drive-thru, mobile order-and-pay, and third-party delivery. Starbucks Rewards had 34.2m 90-day-active U.S. members at fiscal 2025 year-end and 35.5m at January 2026, and the programme drove nearly 60% of U.S. company-operated revenue in fiscal 2025 (2026 Investor Day, 29 January 2026). - **Licensee operators** — regional master licensees and franchisees who buy product, equipment and supplies from Starbucks and remit royalties. Concentration among a small number of large regional licensees is explicitly flagged as a risk factor. - **Grocery, club and convenience retail** — served through Nestlé under the Global Coffee Alliance. - **Foodservice accounts** — offices, hotels, universities, hospitals, airlines and airports. - **Joint-venture partners** — the North American Coffee Partnership with PepsiCo for ready-to-drink, and from April 2026 the Boyu Capital joint venture in China in which Starbucks retains 40%. No single customer accounts for 10% or more of revenues (FY2025 Form 10-K). ---

Company Headquarters: Bromma, Sweden Founded: 2006 Company Working: Moberg Pharma AB develops patented topical pharmaceuticals for the treatment of common disorders through the use of innovative drug delivery. The company comprises only one area of operation, which is the development and commercialization of medical products. MOB-015 is the next generation of nail fungus treatment and BUPI is a new pain treatment for mouth and throat for cancer patients with oral mucositis. MOB-015 is currently undergoing two parallel phase 3 studies with expected topline results towards the end of 2019 and the second quarter of 2020, respectively. It has also signed two license agreements with leading players in Europe and Canada. It markets its products directly in the US, as well as through a network of distributors in approximately 40 countries.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: La Garde, France Founded: 1936 Workforce: NA Company Working: The ECA Group operates as a subsidiary of the Gorgé Group. It is experienced in robotics, automation systems, simulation, and industrial processes. The ECA Group is also engaged in developing complete and innovative technological solutions for complex missions in hostile and confined environments. Through its robotics division, it provides AUVs for various applications such as pipeline inspection, platform surveillance, search and rescue, detection and classification, and intelligence. It serves its products and solutions for customers mainly operating in the defense, maritime, aerospace, simulation, energy, and industrial equipment.

Company Headquarters: Russia Founded: 1967 Workforce: NA Company Working: PJSC Nizhnekamskneftekhim engages in the production of petrochemical products. The company is the leading producer of synthetic rubbers and plastic in Russia. It offers more than 120 products including specialty synthetic rubber, polystyrene, polypropylene, ABS-plastics, and other petrochemical products such as ethylene oxide, propylene oxide, alpha-olefins, and surfactants.

Company Headquarters: US Founded: 1860 Revenue: 103.81 million Company Working: Living Essentials, LLC is an American company that produces a line of energy drinks under the brand name 5-hour ENERGY. The company was founded in 2004 and is headquartered in Farmington Hills, Michigan. 5-hour ENERGY is a small 1.93 fluid ounce (57 ml) energy shot that is designed to provide a quick energy boost without the calories or sugar found in many other energy drinks. It contains a blend of caffeine, B-vitamins, amino acids, and other ingredients, and is available in several flavors, including original, extra strength, decaf, and several different flavors like berry, peach mango, and grape. In addition to energy drinks, Living Essentials also produces protein shakes and vitamin supplements under the brand name Celsius. Celsius is a line of fitness drinks designed to help with weight loss, endurance, and performance. Celsius products are available in several flavors and varieties, including carbonated and non-carbonated options. Living Essentials primarily serves customers in the United States and Canada, but their products are also available in other parts of the world through various distribution channels. 5-hour ENERGY® is a liquid energy shot that provides a feeling of energy and alertness that lasts for hours. Regular Strength 5-hour ENERGY® shots contain a blend of B-vitamins and amino acids, zero sugar, four calories, and caffeine comparable to a cup of the leading premium coffee. Extra Strength 5-hour ENERGY® shots contain caffeine comparable to 12 ounces of the leading premium coffee. It is available at retail outlets in the United States and Canada, and comes in 10 great flavors (Regular Strength Berry, Pomegranate, Lemon-Lime, Grape, Orange and Pink Lemonade; and Extra Strength Strawberry Watermelon, Grape, Berry, and Sour Apple) as well as Decaf.

DNV GL is an international company with headquarters at Oslo, Norway and was established in the year 2013. DNV GL provides classification, technical assurance, software, and independent expert advisory services for operators in oil and gas industries. The company has about 13,550 employees in 350 offices operating in more than 100 countries such as U.S., India, U.K., Australia and Spain. The company operates in five main sectors: Maritime, Oil & Gas, Energy, Business Assurance and Software. They also provide services for several other industries such as renewable, energy, food and beverage and healthcare. DNV GL’s oil and gas services is an industry leading technical advisory services for offshore decommissioning industry in pipeline evaluation, digitisation and subsea structure removal. With their leading technical and operational expertise, DNV GL also provides certification services across wide range of industries. The subsidiaries of the company includes companies such as KEMA, GL Noble Denton, Petro Services A/S, and GL Garrad Hassan Ltd. DNV GL competes with companies such as TechnipFMC PLC, AF Gruppen ASA., Aker Solutions ASA, Allseas Group S.A and Ramboll Group A/S.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Northrop Grumman Corporation (Northrop Grumman) develops security-related products and solutions related to the aerospace and defense industry. Acoustic sensors, unmanned systems, cyber and controls, communications, computers, intelligence, surveillance strike aircraft, and logistics are some of the products and security services provided by the company to the government and commercial sectors worldwide. Northrop Grumman operates through four business segments, namely, aerospace systems, innovation systems, mission systems, and technology services.

Company Headquarter: New York, US Founded: 1997 Workforce: More than 30,000 Company Working: L3 Technologies is a leading provider of a wide range of communication, electronic, and sensor systems used in military, homeland security, and commercial platforms. It is also a prime contractor in aerospace systems, security and detection systems, and pilot training. It operates in four business segments, namely electronics, aerospace, communication, and sensor systems. It operates in 11 countries. L3 Advanced Laser Systems Technology, a subsidiary of L-3 technologies Inc., is an international manufacturer of civil and defense electro-optics. The firm provides advanced solutions for surveillance and reconnaissance missions in sea, land, dismounted, air, and space platforms.

Company Headquarters: Sweden Founded: 1996 Workforce: ~NA Company Working: NetEnt AB is a Swedish digital entertainment company, providing casino systems and online gaming solutions to its users. The company offers around 200 gaming solutions in 24 languages with related technical support. Furthermore, the company has various subsidiaries including Red Tiger Gaming Limited, Net Entertainment Malta Ltd, and Netent Americas LLC. The company has a wide geographical presence across the US and various countries in Europe.

Company Headquarters: Florida, US Founded: 2007 Workforce: ~N/A Company Working: INVO Bioscience is a major medical device company that offers simplified and low-cost treatments for patients who are diagnosed with infertility. The company is majorly focused on the treatment of infertility through its assisted reproductive technology (ART). INVO is a FDA-approved medical device used for natural in-vivo incubation of eggs and sperms during the fertilization and early embryo development phase which acts as an alternative to traditional Intrauterine Insemination (IUI) and In-Vitro Fertilization (IVF) systems. It has a strong presence across the Americas.

Company Headquarters: California, US Founded: 2007 Company Working: Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company engaging in the discovery and development of drugs that target microRNAs to treat a range of diseases in the US and Europe. Its two lead products include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease and RGLS4326, an anti-miR targeting miR-17, which is in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for Hepatitis B virus, NASH, and other infectious diseases.

Company Headquarters: California, US Founded: 1995 Company Working: Prometheus Laboratories Inc. (Prometheus) is engaged in the development and commercialization of pharmaceutical and diagnostic products that enable physicians to provide individualized patient care. The company offers Anser IFX and Anser ADA monitoring assays, non-invasive tests, and inflammation markers in the smart diagnostic algorithm for added diagnostic clarity, celiac tests, and thiopurine monitoring tests, among others. Prometheus operates as a subsidiary of Nestlé.

Company Headquarters: Codolet, France Founded: 1985 Company Working: Cisbio is a life sciences company involved in the manufacturing of assays and reagents. It offers kits and reagents to address the G protein-coupled receptor activation pathway, cellular protein assays, non-phosphorylated proteins assays, and receptor binding assays, among others. The company provides its products for various therapeutic areas, including cardiovascular, infectious diseases, inflammation/immunology, metabolism/diabetes, neurosciences, oncology, and rare diseases. It has its facilities in France, the US, and China, as well as a network of sales offices and distributors across the globe. As Cisbio operates as a subsidiary of PerkinElmer, Inc., the financials mentioned are of the parent company.

Broadcom Inc. (Broadcom) provides a range of semiconductors, including complex digital and mixed-signal complementary metal oxide semiconductor (CMOS)-based devices and analog III-V-based products. It operates through four segments—wired infrastructure, wireless communications, enterprise storage, and industrial & others. The wired infrastructure segment provides a broad set of standard Ethernet switching technologies to deliver system-on-chips (SoCs) for high-performance computing applications and high-speed serializer/deserializer technology integrated with application-specific integrated circuits (ASICs). It also offers semiconductor solutions for set-top boxes, digital subscriber line cable, and fiber broadband access markets. The segment also provides transceivers that transmit and receive Ethernet data packets through copper wires or optical fiber cables. Broadcom provides optical laser and receiver components for Ethernet networking and access, metro, and long-haul telecommunication networks. The wireless communication segment offers a variety of radio frequency (RF) semiconductor devices that amplify and filter RF signals. The enterprise storage segment offers products designed to enable secure movement of digital data to and from host machines, such as servers, personal computers, and storage systems, to underlying storage devices including hard disk drives (HDDs) and solid-state drives (SSDs). The products offered by the company include enterprise and data center networking, home connectivity, broadband access, telecommunications equipment, smartphones, data center servers and storage, factory automation, power generation and alternative energy systems, and electronic displays. Geographically, the company operates in the US, China, and Singapore, among others.

Juniper Networks, Inc. engages in the sales of products and services, design, and development, for high-performance networks. The company operates in various business segments, including switching, routing, and security products, which are designed to provide high performance, flexibility, and low total ownership cost. The company operates across more than 100 countries in EMEA, the Americas, and Asia-Pacific. Few subsidiaries of Juniper Networks are AppFormix Inc, Cyphort Inc., WANDL Inc., and Altor Networks. The major competitors of Juniper Networks are Cisco Systems, Arista Networks, Hewlett Packard Enterprise, Alcatel-Lucent Enterprise, and Huawei Technologies Co. Ltd. The company operates globally.

Company Headquarter: Mumbai, India Founded: 1968 Workforce: 15,000+ Company Working: Lupin is a global pharmaceutical company that deals in a wide range of products such as branded and generic formulations, biotechnology products, APIs, and specialty drugs. The company is a prominent player in the therapeutic segment such as gynecology, cardiovascular, diabetology, asthma, pediatric, central nervous system, gastrointestinal (GI), anti-infective (AI), and non-steroidal anti-inflammatory drugs (NSAIDS). Also, it has a global leader in the fields of the anti-TB and Cephalosporin segment. Lupin has a presence in more than 100 countries. It has 18 manufacturing facilities, located in many parts of India, Japan, the US, Mexico, and Brazil. All these facilities are benchmarked to international standards to meet stringent quality standards. Also, these facilities are approved by international agencies such as the US FDA, UK MHRA, Japan’s MHLW, TGA Australia, WHO, and the MCC South Africa.